Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison Barraclough

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Seminars in Hematology|December 10, 2023
Antibody and immunotherapy in diffuse large B-cell lymphomaAllison Barraclough, Eliza A Hawkes
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 23, 2012
Brachial neuritis with phrenic nerve involvementAllison Barraclough, James Triplett, Philip Tuch
Blood|February 12, 2025
Emerging biomarkers for CD3×CD20 bispecific antibodies in lymphomaCameron S Lewis, Allison Barraclough, Eliza A Hawkes
Blood|December 21, 2021
Limited-stage diffuse large B-cell lymphomaEliza A Hawkes, Allison Barraclough, Laurie H Sehn
Hematological Oncology|July 12, 2023
Diffuse large B-cell lymphomaAllison Barraclough, Eliza Hawkes, Laurie H Sehn, et al.
British Journal of Haematology|March 11, 2021
The diagnostic and therapeutic challenges of Grade 3B follicular lymphomaAllison Barraclough, Mark Bishton, Chan Y Cheah, et al.
British Journal of Haematology|April 14, 2021
Evolution of eligibility criteria for diffuse large B-cell lymphoma randomised controlled trials over 30 yearsZoe Loh, Ross Salvaris, Geoffrey Chong, et al.
British Journal of Haematology|October 13, 2024
The value of semiquantitative PET features and end-of-therapy PET in grade 3B follicular lymphomaAllison Barraclough, Sze Ting Lee, Diego Villa, et al.
Internal Medicine Journal|November 23, 2024
Diagnosis and management of mantle cell lymphoma: a consensus practice statement from the Australasian Lymphoma AllianceAllison Barraclough, Catherine Tang, Masa Lasica, et al.
Internal Medicine Journal|December 20, 2021
Diagnosis and management of primary central nervous system lymphoma: a consensus practice statement from the Australasian Lymphoma AllianceColm Keane, Nada Hamad, Allison Barraclough, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Seminars in Hematology|December 10, 2023
Antibody and immunotherapy in diffuse large B-cell lymphomaAllison Barraclough, Eliza A Hawkes
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 23, 2012
Brachial neuritis with phrenic nerve involvementAllison Barraclough, James Triplett, Philip Tuch
Blood|February 12, 2025
Emerging biomarkers for CD3×CD20 bispecific antibodies in lymphomaCameron S Lewis, Allison Barraclough, Eliza A Hawkes
Blood|December 21, 2021
Limited-stage diffuse large B-cell lymphomaEliza A Hawkes, Allison Barraclough, Laurie H Sehn
Hematological Oncology|July 12, 2023
Diffuse large B-cell lymphomaAllison Barraclough, Eliza Hawkes, Laurie H Sehn, et al.
British Journal of Haematology|March 11, 2021
The diagnostic and therapeutic challenges of Grade 3B follicular lymphomaAllison Barraclough, Mark Bishton, Chan Y Cheah, et al.
British Journal of Haematology|April 14, 2021
Evolution of eligibility criteria for diffuse large B-cell lymphoma randomised controlled trials over 30 yearsZoe Loh, Ross Salvaris, Geoffrey Chong, et al.
British Journal of Haematology|October 13, 2024
The value of semiquantitative PET features and end-of-therapy PET in grade 3B follicular lymphomaAllison Barraclough, Sze Ting Lee, Diego Villa, et al.
Internal Medicine Journal|November 23, 2024
Diagnosis and management of mantle cell lymphoma: a consensus practice statement from the Australasian Lymphoma AllianceAllison Barraclough, Catherine Tang, Masa Lasica, et al.
Internal Medicine Journal|December 20, 2021
Diagnosis and management of primary central nervous system lymphoma: a consensus practice statement from the Australasian Lymphoma AllianceColm Keane, Nada Hamad, Allison Barraclough, et al.
Pageof 3